Champions Oncology Files 8-K on Financials
Ticker: CSBR · Form: 8-K · Filed: Sep 11, 2024 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 8-K |
| Filed Date | Sep 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
TL;DR
Champions Oncology dropped an 8-K detailing its financial condition and operations as of Sept 11, 2024.
AI Summary
Champions Oncology, Inc. filed an 8-K on September 11, 2024, reporting on its results of operations and financial condition. The filing details the company's financial statements and exhibits, providing an update on its business operations. The company, previously known as Champions Biotechnology, Inc., is incorporated in Delaware and has its principal executive offices in Hackensack, NJ.
Why It Matters
This 8-K filing provides investors with crucial updates on Champions Oncology's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Registrant
- September 11, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Hackensack, NJ (location) — Business Address City and State
- CHAMPIONS BIOTECHNOLOGY, INC. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing for Champions Oncology, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, including its Financial Statements and Exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on September 11, 2024.
In which state is Champions Oncology, Inc. incorporated?
Champions Oncology, Inc. is incorporated in Delaware.
What were previous names of Champions Oncology, Inc.?
Previous names include Champions Biotechnology, Inc. and Champions Sports Inc.
What is the business address of Champions Oncology, Inc.?
The business address is 1 University Plaza, Suite 307, Hackensack, NJ.
Filing Stats: 462 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-09-11 16:34:00
Filing Documents
- csbr-20240911.htm (8-K) — 32KB
- csbr8-k7312024ex991xq125.htm (EX-99.1) — 129KB
- logobranding_headerleftali.jpg (GRAPHIC) — 31KB
- 0001628280-24-040137.txt ( ) — 334KB
- csbr-20240911.xsd (EX-101.SCH) — 2KB
- csbr-20240911_def.xml (EX-101.DEF) — 3KB
- csbr-20240911_lab.xml (EX-101.LAB) — 21KB
- csbr-20240911_pre.xml (EX-101.PRE) — 12KB
- csbr-20240911_htm.xml (XML) — 2KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On September 11, 2024, Champions Oncology, Inc. (the "Company") issued a press release regarding the Company's unaudited financial results for its first quarter ended July 31, 2024. A copy of the Company's press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is filed herewith: Exhibit No. 99.1 Press Release dated September 11, 2024
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CHAMPIONS ONCOLOGY, INC. (Registrant) Date: March 12, 2024 By: /s/ Ronnie Morris Ronnie Morris Chief Executive Officer